Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Rapid Whole Genome Sequencing Has Clinical Utility in Children in the PICU.

Sanford EF, Clark MM, Farnaes L, Williams MR, Perry JC, Ingulli EG, Sweeney NM, Doshi A, Gold JJ, Briggs B, Bainbridge MN, Feddock M, Watkins K, Chowdhury S, Nahas SA, Dimmock DP, Kingsmore SF, Coufal NG; RCIGM Investigators.

Pediatr Crit Care Med. 2019 Jun 19. doi: 10.1097/PCC.0000000000002056. [Epub ahead of print]

PMID:
31246743
2.

Root cause analysis of limitations of virtual crossmatch for kidney allocation to highly-sensitized patients.

Jani V, Ingulli E, Mekeel K, Morris GP.

Hum Immunol. 2017 Feb;78(2):72-79. doi: 10.1016/j.humimm.2016.11.003. Epub 2016 Nov 15.

PMID:
27864154
3.

Growth in children with chronic kidney disease: role of nutrition, growth hormone, dialysis, and steroids.

Ingulli EG, Mak RH.

Curr Opin Pediatr. 2014 Apr;26(2):187-92. doi: 10.1097/MOP.0000000000000070. Review.

PMID:
24535500
4.

Principles of memory CD8 T-cells generation in relation to protective immunity.

Zanetti M, Castiglioni P, Ingulli E.

Adv Exp Med Biol. 2010;684:108-25. Review.

PMID:
20795544
5.

Mechanism of cellular rejection in transplantation.

Ingulli E.

Pediatr Nephrol. 2010 Jan;25(1):61-74. doi: 10.1007/s00467-008-1020-x. Review.

6.

Levetiracetam induced interstitial nephritis and renal failure.

Hurwitz KA, Ingulli EG, Krous HF.

Pediatr Neurol. 2009 Jul;41(1):57-8. doi: 10.1016/j.pediatrneurol.2009.01.011.

PMID:
19520278
7.

Extended-working-distance multiphoton micromanipulation microscope for deep-penetration imaging in live mice and tissue.

Makale M, McElroy M, O'Brien P, Hoffman RM, Guo S, Bouvet M, Barnes L, Ingulli E, Cheresh D.

J Biomed Opt. 2009 Mar-Apr;14(2):024032. doi: 10.1117/1.3103783.

8.

Cutting edge: antigen presentation to CD8 T cells after influenza A virus infection.

Ingulli E, Funatake C, Jacovetty EL, Zanetti M.

J Immunol. 2009 Jan 1;182(1):29-33.

9.

Protection against influenza A virus by memory CD8 T cells requires reactivation by bone marrow-derived dendritic cells.

Castiglioni P, Hall de S, Jacovetty EL, Ingulli E, Zanetti M.

J Immunol. 2008 Apr 1;180(7):4956-64.

10.

Acute poststreptococcal glomerulonephritis: an update.

Ahn SY, Ingulli E.

Curr Opin Pediatr. 2008 Apr;20(2):157-62. doi: 10.1097/MOP.0b013e3282f45bcf. Review.

PMID:
18332711
11.

Tracing tolerance and immunity in vivo by CFSE-labeling of administered cells.

Ingulli E.

Methods Mol Biol. 2007;380:365-76. Review.

PMID:
17876106
12.

Increased urologic complications in children after kidney transplants for obstructive and reflux uropathy.

Khositseth S, Askiti V, Nevins TE, Matas AJ, Ingulli EG, Najarian JS, Gillingham KJ, Chavers BM.

Am J Transplant. 2007 Sep;7(9):2152-7.

13.

MHC class II deprivation impairs CD4 T cell motility and responsiveness to antigen-bearing dendritic cells in vivo.

Fischer UB, Jacovetty EL, Medeiros RB, Goudy BD, Zell T, Swanson JB, Lorenz E, Shimizu Y, Miller MJ, Khoruts A, Ingulli E.

Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7181-6. Epub 2007 Apr 13.

14.

Cat-scratch disease relapse in a kidney transplant recipient.

Rheault MN, van Burik JA, Mauer M, Ingulli E, Ferrieri P, Jessurun J, Chavers BM.

Pediatr Transplant. 2007 Feb;11(1):105-9.

PMID:
17239132
15.

CD154+ graft antigen-specific CD4+ T cells are sufficient for chronic rejection of minor antigen incompatible heart grafts.

Huddleston SJ, Hays WS, Filatenkov A, Ingulli E, Jenkins MK.

Am J Transplant. 2006 Jun;6(6):1312-9.

16.

Phenotype and homing of CD4 tumor-specific T cells is modulated by tumor bulk.

Benigni F, Zimmermann VS, Hugues S, Caserta S, Basso V, Rivino L, Ingulli E, Malherbe L, Glaichenhaus N, Mondino A.

J Immunol. 2005 Jul 15;175(2):739-48.

17.

CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of tolerance.

Filatenkov AA, Jacovetty EL, Fischer UB, Curtsinger JM, Mescher MF, Ingulli E.

J Immunol. 2005 Jun 1;174(11):6909-17.

18.

Cyclosporine toxicity in immunosuppressed streptozotocin-diabetic nonhuman primates.

Wijkstrom M, Kirchhof N, Graham M, Ingulli E, Colvin RB, Christians U, Hering BJ, Schuurman HJ.

Toxicology. 2005 Feb 1;207(1):117-27.

PMID:
15590127
19.
20.

Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity.

Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, Rudensky AY, Jenkins MK.

Immunity. 2003 Jul;19(1):47-57.

21.
22.

The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivo.

Harmala LA, Ingulli EG, Curtsinger JM, Lucido MM, Schmidt CS, Weigel BJ, Blazar BR, Mescher MF, Pennell CA.

J Immunol. 2002 Nov 15;169(10):5622-9.

24.

Single-cell analysis of signal transduction in CD4 T cells stimulated by antigen in vivo.

Zell T, Khoruts A, Ingulli E, Bonnevier JL, Mueller DL, Jenkins MK.

Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10805-10. Epub 2001 Sep 4.

25.

CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells.

Blazar BR, Lindberg FP, Ingulli E, Panoskaltsis-Mortari A, Oldenborg PA, Iizuka K, Yokoyama WM, Taylor PA.

J Exp Med. 2001 Aug 20;194(4):541-9.

26.

Cutting edge: in vivo identification of TCR redistribution and polarized IL-2 production by naive CD4 T cells.

Reichert P, Reinhardt RL, Ingulli E, Jenkins MK.

J Immunol. 2001 Apr 1;166(7):4278-81.

27.

In vivo activation of antigen-specific CD4 T cells.

Jenkins MK, Khoruts A, Ingulli E, Mueller DL, McSorley SJ, Reinhardt RL, Itano A, Pape KA.

Annu Rev Immunol. 2001;19:23-45. Review.

PMID:
11244029
28.

TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo.

Josien R, Li HL, Ingulli E, Sarma S, Wong BR, Vologodskaia M, Steinman RM, Choi Y.

J Exp Med. 2000 Feb 7;191(3):495-502.

29.

Antigen-specific CD4+ T cells that survive after the induction of peripheral tolerance possess an intrinsic lymphokine production defect.

Pape KA, Khoruts A, Ingulli E, Mondino A, Merica R, Jenkins MK.

Novartis Found Symp. 1998;215:103-13; discussion 113-9, 186-90. Review.

PMID:
9760574
30.

Visualization of specific B and T lymphocyte interactions in the lymph node.

Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK.

Science. 1998 Jul 3;281(5373):96-9.

31.

In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.

Ingulli E, Mondino A, Khoruts A, Jenkins MK.

J Exp Med. 1997 Jun 16;185(12):2133-41.

32.

Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cell for the study of T-cell activation in vivo.

Pape KA, Kearney ER, Khoruts A, Mondino A, Merica R, Chen ZM, Ingulli E, White J, Johnson JG, Jenkins MK.

Immunol Rev. 1997 Apr;156:67-78. Review.

PMID:
9176700
33.

Impact of age on renal graft survival in children after the first rejection episode.

Ingulli E, Matas AJ, Nevins TE, Kashtan CE, Mauer SM, Gillingham K, Chavers BM.

Pediatr Nephrol. 1996 Aug;10(4):474-8.

PMID:
8865246
34.

Focal segmental glomerulosclerosis in children.

Ingulli E, Tejani A.

Curr Opin Pediatr. 1995 Apr;7(2):176-81. Review.

PMID:
7787934
35.

Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis.

Ingulli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A.

J Am Soc Nephrol. 1995 Apr;5(10):1820-5.

36.

Cyclosporin in steroid-resistant idiopathic nephrotic syndrome.

Tejani A, Ingulli E.

Contrib Nephrol. 1995;114:73-7. Review. No abstract available.

PMID:
7587201
37.

Current concepts of pathogenesis of nephrotic syndrome.

Tejani A, Ingulli E.

Contrib Nephrol. 1995;114:1-5. Review. No abstract available.

PMID:
7587194
38.

An analytical review of growth hormone studies in children after renal transplantation.

Ingulli E, Tejani A.

Pediatr Nephrol. 1995;9 Suppl:S61-5. Review.

PMID:
7492490
39.

Prednisone inhibits the efficacy of recombinant human growth hormone in pediatric renal transplant recipients.

Ingulli E, Singh A, Moazami S, Tejani A.

Kidney Int Suppl. 1993 Oct;43:S65-70.

PMID:
8246373
40.

Steroid withdrawal, rejection and the mixed lymphocyte reaction in children after renal transplantation.

Ingulli E, Sharma V, Singh A, Suthanthiran M, Tejani A.

Kidney Int Suppl. 1993 Oct;43:S36-9.

PMID:
8246367
41.
44.

Nephrotic syndrome associated with acquired immunodeficiency syndrome in children.

Ingulli E, Tejani A, Fikrig S, Nicastri A, Chen CK, Pomrantz A.

J Pediatr. 1991 Nov;119(5):710-6.

PMID:
1941375
45.
47.

High-dose cyclosporine therapy in recurrent nephrotic syndrome following renal transplantation.

Ingulli E, Tejani A, Butt KM, Rajpoot D, Gonzalez R, Pomrantz A, Ettenger R.

Transplantation. 1990 Jan;49(1):219-21. No abstract available.

PMID:
2301015
48.

Poststreptococcal glomerulonephritis. Current clinical and pathologic concepts.

Tejani A, Ingulli E.

Nephron. 1990;55(1):1-5. Review. No abstract available.

PMID:
2191230
49.

Nephrotic syndrome: from toddlers to twenties.

Ingulli E, Gonzalez R, Rajpoot D, Tejani A.

Lancet. 1989 Mar 25;1(8639):674. No abstract available.

PMID:
2564492
50.

Long-term outcome of one haploidentical live related donor transplantation in children.

Ingulli E, Gonzalez R, Rajpoot D, Pomrantz A, Sumrani N, Hong J, Butt KM, Tejani A.

Child Nephrol Urol. 1988-1989;9(6):312-8.

PMID:
3272851

Supplemental Content

Loading ...
Support Center